Midkine Symposium April 2016: The role of pleiotrophin in angiogenesis




Episode Loading...




PharmaTelevision requires Javascript enabled and Adobe Flash Player to watch our programmes. If you do not have Flash installed, you can download it for free from the Adobe Flash homepage.

Improve your Internet experience and start watching exciting new video content.

Video title: Midkine Symposium April 2016: The role of pleiotrophin in angiogenesis
Released on: June 27, 2016. © PharmaVentures Ltd
Share/save this page:
Email
Bookmark
Facebook
Twitter
LinkedIn
Follow us:
RSS
Twitter
In This Episode:
    Professor Evangelia Papadimitriou, Professor of Molecular Pharmacology (Department of Pharmacy, School of Health Sciences University of Patras, Greece), describes the pro and anti-angiogenic properties of pleiotrophin and the development of novel molecules to supplement existing anti-angiogenic therapies.
  • Summary
  • Transcript
  • Participants
  • Company
Professor Evangelia Papadimitriou, Professor of Molecular Pharmacology (Department of Pharmacy, School of Health Sciences University of Patras, Greece), describes the pro and anti-angiogenic properties of pleiotrophin and the development of novel molecules to supplement existing anti-angiogenic therapies.
Professor Evangelia Papadimitriou, Professor of Molecular Pharmacology (Department of Pharmacy, School of Health Sciences University of Patras, Greece), describes the pro and anti-angiogenic properties of pleiotrophin and the development of novel molecules to supplement existing anti-angiogenic therapies.
Prof. Evangelia Papadimitriou
Department of Pharmacy, School of Health Sciences, University of Patras, Patras, Greece